These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38718959)

  • 1. Integrative transcriptomics and proteomics analysis reveal the protection of Astragaloside IV against myocardial fibrosis by regulating senescence.
    Shi L; Deng J; He J; Zhu F; Jin Y; Zhang X; Ren Y; Du X
    Eur J Pharmacol; 2024 Jul; 975():176632. PubMed ID: 38718959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV Prevents Cardiac Remodeling in the Apolipoprotein E-Deficient Mice by Regulating Cardiac Homeostasis and Oxidative Stress.
    Li XZ; Ding YZ; Wu HF; Bian ZP; Xu JD; Gu CR; Chen XJ; Yang D
    Cell Physiol Biochem; 2017; 44(6):2422-2438. PubMed ID: 29268252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy.
    Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G
    J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV attenuate MI-induced myocardial fibrosis and cardiac remodeling by inhibiting ROS/caspase-1/GSDMD signaling pathway.
    Zhang X; Qu H; Yang T; Liu Q; Zhou H
    Cell Cycle; 2022 Nov; 21(21):2309-2322. PubMed ID: 35770948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV protects against the pathological cardiac hypertrophy in mice.
    Liu ZH; Liu HB; Wang J
    Biomed Pharmacother; 2018 Jan; 97():1468-1478. PubMed ID: 29793309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV Alleviates the Myocardial Damage Induced by Lipopolysaccharide via the Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB)/Proliferator-Activated Receptor α (PPARα) Signaling Pathway.
    Zhang X; Li M; Wang H
    Med Sci Monit; 2019 Sep; 25():7158-7168. PubMed ID: 31545785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.
    Lin J; Fang L; Li H; Li Z; Lyu L; Wang H; Xiao J
    Eur J Pharmacol; 2019 Sep; 859():172490. PubMed ID: 31229536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV ameliorates radiation-induced senescence via antioxidative mechanism.
    Liu X; Shang S; Chu W; Ma L; Jiang C; Ding Y; Wang J; Zhang S; Shao B
    J Pharm Pharmacol; 2020 Aug; 72(8):1110-1118. PubMed ID: 32412100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV attenuates chronic intermittent hypoxia-induced myocardial injury by modulating Ca
    Jiang S; Jiao G; Chen Y; Han M; Wang X; Liu W
    Cell Biochem Funct; 2020 Aug; 38(6):710-720. PubMed ID: 32306464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanism of Astragaloside IV in Treating Bleomycin-Induced Pulmonary Fibrosis.
    Yuan S; Zuo B; Zhou SC; Wang M; Tan KY; Chen ZW; Cao WF
    Drug Des Devel Ther; 2023; 17():1289-1302. PubMed ID: 37138582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway.
    Wei Y; Wu Y; Feng K; Zhao Y; Tao R; Xu H; Tang Y
    J Ethnopharmacol; 2020 Mar; 249():112404. PubMed ID: 31739105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro.
    Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q
    Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein.
    Huang H; Lai S; Wan Q; Qi W; Liu J
    Can J Physiol Pharmacol; 2016 May; 94(5):542-53. PubMed ID: 27070866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV Regulates the PI3K/Akt/HO-1 Signaling Pathway and Inhibits H9c2 Cardiomyocyte Injury Induced by Hypoxia-Reoxygenation.
    Yang P; Zhou Y; Xia Q; Yao L; Chang X
    Biol Pharm Bull; 2019 May; 42(5):721-727. PubMed ID: 30867343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.
    Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H
    Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid attenuates remodeling and dysfunction in the aging heart through the ER stress pathway.
    Ye S; Zhou X; Chen P; Lin JF
    Life Sci; 2021 Jan; 264():118718. PubMed ID: 33160997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV inhibits astrocyte senescence: implication in Parkinson's disease.
    Xia ML; Xie XH; Ding JH; Du RH; Hu G
    J Neuroinflammation; 2020 Apr; 17(1):105. PubMed ID: 32252767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of astragaloside IV on lipopolysaccharide-induced cardiac dysfunction via downregulation of inflammatory signaling in mice.
    Zhao P; Wang Y; Zeng S; Lu J; Jiang TM; Li YM
    Immunopharmacol Immunotoxicol; 2015; 37(5):428-33. PubMed ID: 26376109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4/MyD88/NF-κB signaling pathway.
    Shi H; Zhou P; Gao G; Liu PP; Wang SS; Song R; Zou YY; Yin G; Wang L
    J Food Biochem; 2021 Jul; 45(7):e13757. PubMed ID: 34032295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside exerts anti-photoaging effects in UVB-induced premature senescence of rat dermal fibroblasts through enhanced autophagy.
    Wen W; Chen J; Ding L; Luo X; Zheng X; Dai Q; Gu Q; Liu C; Liang M; Guo X; Liu P; Li M
    Arch Biochem Biophys; 2018 Nov; 657():31-40. PubMed ID: 30222953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.